Latest news
Immuneering Reports 17.3-Month Median Overall Survival in First-Line Pancreatic Cancer and Progresses Phase 3 MAPKeeper 301 Trial - Quiver QuantitativeQuiver Quantitative · Wed, 05 Aug 2026 11:43:00 GMTProphylactic Cranial Irradiation Improves Survival in Limited-Stage SCLC - CancerNetworkCancerNetwork · Tue, 04 Aug 2026 15:08:44 GMT